Although the Sambarey10 signature (FCGR1A, HK3, RAB13, RBBP8, IFI44L, TIMM10, BCL6, SMARCD3, CYP4F3, SLPI) showed promising performance in TB diagnosis, it has not been evaluated for the monitoring of treatment responses (12, 13, 17). This evidence concerns the gene FCGR1A and tuberculosis.